Sansure Biotech Inc (688289) - Total Liabilities

Latest as of March 2026: CN¥2.38 Billion CNY ≈ $347.87 Million USD

Based on the latest financial reports, Sansure Biotech Inc (688289) has total liabilities worth CN¥2.38 Billion CNY (≈ $347.87 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688289 net asset momentum to track the company's year-over-year net asset growth rate.

Sansure Biotech Inc - Total Liabilities Trend (2017–2025)

This chart illustrates how Sansure Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. See 688289 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Sansure Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Sansure Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
JM Financial Limited NSE:JMFINANCIL	India	Rs136.71 Billion
Suzhou Huaya Intelligence Technology Co Ltd SHE:003043	China	CN¥1.02 Billion
Cogeco Communications Inc TO:CCA	Canada	CA$5.92 Billion
Henan Thinker Automation SHG:603508	China	CN¥315.73 Million
Herbalife Nutrition Ltd NYSE:HLF	USA	$3.30 Billion
Guizhou Broadcasting&TV Info SHG:600996	China	CN¥12.24 Billion
Cpi Fim SA WAR:OPG	Poland	zł4.75 Billion
Westamerica Bancorporation NASDAQ:WABC	USA	$5.03 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Sansure Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Sansure Biotech Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sansure Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sansure Biotech Inc (2017–2025)

The table below shows the annual total liabilities of Sansure Biotech Inc from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥-7.22 Billion ≈ $-1.06 Billion	-673.93%
2024-12-31	CN¥1.26 Billion ≈ $184.09 Million	+22.22%
2023-12-31	CN¥1.03 Billion ≈ $150.62 Million	-38.03%
2022-12-31	CN¥1.66 Billion ≈ $243.05 Million	+134.26%
2021-12-31	CN¥709.03 Million ≈ $103.75 Million	+0.01%
2020-12-31	CN¥708.95 Million ≈ $103.74 Million	+734.17%
2019-12-31	CN¥84.99 Million ≈ $12.44 Million	-45.43%
2018-12-31	CN¥155.76 Million ≈ $22.79 Million	-16.54%
2017-12-31	CN¥186.62 Million ≈ $27.31 Million	--

About Sansure Biotech Inc

SHG:688289 China Medical Instruments & Supplies

Market Cap

$1.30 Billion

CN¥8.91 Billion CNY

Market Cap Rank

#7762 Global

#1743 in China

Share Price

CN¥15.37

Change (1 day)

-0.77%

52-Week Range

CN¥13.87 - CN¥22.31

All Time High

CN¥81.40